Paxlovid Archives | Be Korea-savvy

Home / Posts tagged Paxlovid

VV116 Versus PAXLOVID Phase III Registrational Trial for Early Treatment of Mild to Moderate COVID-19 in High Risk Patients Reaches Primary Endpoint

SHANGHAI, China, May 25 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the Phase III clinical study (NCT05341609) comparing the efficacy and safety of VV116 (JT001) and nirmatrelvir/ritonavir (“PAXLOVID”) in the [...]

81 pct of Paxlovid Takers Show Improvement in Symptoms

SEOUL, Feb. 22 (Korea Bizwire) — 8 out of 10 patients who took Paxlovid, a pill against COVID-19 developed by Pfizer Inc., showed improvements in their symptoms, health authorities said Monday. The Central Disease Control Headquarters unveiled the analytical results of the treatment of 364 virus patients who took Paxlovid. Of the total, 352 patients [...]

S. Korea Approves Pfizer’s Oral COVID-19 Pill

SEOUL, Dec. 27 (Korea Bizwire) — South Korea’s drug safety agency on Monday approved an emergency authorization of U.S. drug giant Pfizer Inc.’s oral drug to treat COVID-19, making it the first such pill to be used in the country. Paxlovid is the antiviral pill for the treatment of mild to moderate COVID-19 in patients [...]